CTRI/2024/07/069772Not yet recruitingPhase 3
A controlled clinical study to evaluate the efficacy of Vranaropani (Hemigraphis alternata (Burm.f)) Malahara in the management of sadyovrana. - nil
Dr Surender Redhu0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 3
- Status
- Not yet recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •Patients of age group between 16 to 70 yrs.
- •Kshataja vrana, Chinna vrana.
- •Sadyovrana of following dimensions:
- •Maximum length 5 cm.
- •Maximum width: 5 cm
- •Maximum Depth: 0.5 cm.
- •Patients of either gender.
- •Wounds within 7 days.
Exclusion Criteria
- •Patients with systemic disorders like DM, HTN, Bleeding disorders and dermatological manifestations.
- •Wounds that require suturing.
- •Dushta Vrana (Infected).
- •The patients having Sadyovrana with other complications like fractures Marmaghata etc.
- •Medico-legal cases
Investigators
Similar Trials
Not yet recruiting
Phase 2
Avabahuka management through ayurvedaCTRI/2024/03/063989Pt Khushilal Sharma Government Autonomous Ayurveda College and Institute Bhopal MP
Completed
Phase 2
management of plantar fasciitis by ayurvedic kwath iontophoresisCTRI/2021/05/033429All India Institute of Ayurveda25
Not yet recruiting
Phase 3
To study the effect of Jatyadighrita suppository and Diclofenac suppository in managing the pain after surgery in Anorectal disordersCTRI/2022/09/046069Dr SRINIVASA N V
Not yet recruiting
Phase 2
A clinical study to evaluate the efficacy of Nirgundi taila and Nirgundi malahara in the management of Fissure-in-anoCTRI/2023/12/060815Dr Hari R
Recruiting
Not Applicable
Clinical study on the treatment of asymptomatic and mild patients with COVID-19 by Tibetan MedicineITMCTR2200006549Tibetan Hospital Mentsee Khang of Tibet Autonomous Region